Richele Bettencourt Selected Research

Protons (Proton)

1/2022	Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease.
11/2019	MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richele Bettencourt Research Topics

Disease

4	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2019
2	Fibrosis (Cirrhosis) 01/2022 - 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Lipodystrophy 11/2019
1	Erectile Dysfunction 04/2004

Drug/Important Bio-Agent (IBA)

2	Protons (Proton)IBA 01/2022 - 11/2019
1	TransferasesIBA 01/2022
1	nasIBA 12/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	aramcholIBA 11/2019
1	LipidsIBA 04/2004

Therapy/Procedure

1	Precision Medicine 01/2021